Answers are grounded in this paper and cite their sources.
Retrospective analysis explores biomarkers' association with poor outcomes in young stroke patients, suggesting clinical importance.
Background: Young stroke (age ≤ 45) is a growing global health concern often driven by metabolic factors, with insulin resistance (IR) and dyslipidemia being key contributors. Novel metabolic indices, the Cholesterol–High-Density Lipoprotein–Glucose (CHG) index and the Remnant Cholesterol Inflammatory Index (RCII), have emerged as promising tools, yet their prognostic value in young stroke populations remains unexplored. Methods: We retrospectively analyzed 541 young stroke patients (age ≤ 45 years) between January 2019 and December 2021. The associations between CHG and RCII indices and poor functional outcomes at 90 days and discharge, infarct size, and hemorrhagic transformation were evaluated using multivariate logistic regression, restricted cubic spline (RCS) analysis, and receiver operating characteristic (ROC) curves. Subgroup, interaction, and sensitivity analyses were performed to assess the stability and robustness of the findings. Results: A total of 541 young stroke patients were included (median age 37 years). Patients with poor 90-day functional outcome (modified Rankin Scale ≥ 2) exhibited significantly higher CHG (5.2 vs. 5.1, p = 0.018) and RCII (2.8 vs. 1.7, p < 0.001) levels. After multivariable adjustment, both indices were independently associated with poor 90-day outcome (CHG: OR 1.31 per SD, 95% CI 1.07–1.61; RCII: OR 1.23 per SD, 95% CI 1.04–1.46) and poor discharge outcome. The highest RCII quartile exhibited more than threefold increased odds of a poor 90-day outcome (OR 3.43, 95% CI 1.90–6.20). Both indices were associated with larger lesion size, and RCII was additionally associated with hemorrhagic transformation (Q4 vs. Q1: OR 2.42, 95% CI 1.23–4.75). Restricted cubic spline analyses demonstrated no evidence of non-linearity. Adding RCII to a base clinical model significantly improved discrimination (AUC 0.645 vs. 0.564, DeLong p = 0.004). No significant sex interaction was observed; RCII showed significant interactions with age and TOAST subtype. Conclusions: Both CHG and RCII indices are independently associated with poor functional outcomes, larger infarct size, and—for RCII—hemorrhagic transformation in young patients with acute ischemic stroke. These readily calculable biomarkers may provide complementary prognostic information in this population, though their clinical utility requires further prospective validation.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: